Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition
Journal of Advanced Research
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition. // Journal of Advanced Research. – URL: https://www.sciencedirect.com/science/article/pii/S2090123226001438?dgcid=rss_sd_all
Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition. Journal of Advanced Research. https://www.sciencedirect.com/science/article/pii/S2090123226001438?dgcid=rss_sd_all
“Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition.” Journal of Advanced Research.
@article{article4413,
title = {Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition},
journal = {Journal of Advanced Research},
url = {https://www.sciencedirect.com/science/article/pii/S2090123226001438?dgcid=rss_sd_all}
}